| pubmed-article:19954593 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19954593 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19954593 | lifeskim:mentions | umls-concept:C0023487 | lld:lifeskim |
| pubmed-article:19954593 | lifeskim:mentions | umls-concept:C0039225 | lld:lifeskim |
| pubmed-article:19954593 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:19954593 | lifeskim:mentions | umls-concept:C0205198 | lld:lifeskim |
| pubmed-article:19954593 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:19954593 | pubmed:dateCreated | 2009-12-4 | lld:pubmed |
| pubmed-article:19954593 | pubmed:abstractText | To report the results of curative and adverse effects of compound huangdai tablet (CHDT) as induction therapy for 193 patients with acute promyelocytic leukemia (APL). | lld:pubmed |
| pubmed-article:19954593 | pubmed:language | chi | lld:pubmed |
| pubmed-article:19954593 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19954593 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19954593 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19954593 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19954593 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:19954593 | pubmed:issn | 0253-2727 | lld:pubmed |
| pubmed-article:19954593 | pubmed:author | pubmed-author:YangXiangX | lld:pubmed |
| pubmed-article:19954593 | pubmed:author | pubmed-author:WangXiao-BoXB | lld:pubmed |
| pubmed-article:19954593 | pubmed:author | pubmed-author:HuangShi-LinS... | lld:pubmed |
| pubmed-article:19954593 | pubmed:author | pubmed-author:SunShu-JunSJ | lld:pubmed |
| pubmed-article:19954593 | pubmed:author | pubmed-author:GuoAi-XiaAX | lld:pubmed |
| pubmed-article:19954593 | pubmed:author | pubmed-author:WeiAi-HongAH | lld:pubmed |
| pubmed-article:19954593 | pubmed:author | pubmed-author:ChengYu-BinYB | lld:pubmed |
| pubmed-article:19954593 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19954593 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:19954593 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19954593 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19954593 | pubmed:pagination | 440-2 | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:meshHeading | pubmed-meshheading:19954593... | lld:pubmed |
| pubmed-article:19954593 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19954593 | pubmed:articleTitle | [Compound huangdai tablet as induction therapy for 193 patients with acute promyelocytic leukemia]. | lld:pubmed |
| pubmed-article:19954593 | pubmed:affiliation | Department of Traditional Chinese Medicine & Hematology, 210th Hospital of PLA, Dalian 116021, China. | lld:pubmed |
| pubmed-article:19954593 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19954593 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:19954593 | pubmed:publicationType | English Abstract | lld:pubmed |
